Xanax (alprazolam) is designed for short-term use. The FDA has only confirmed its safety and effectiveness for up to 4 months for generalized anxiety and 4 to 10 weeks for panic disorder. Beyond those windows, there simply isn’t strong clinical evidence that it continues to work, and the risks of dependence and cognitive side effects grow significantly.
What the Clinical Evidence Covers
The FDA label for Xanax is unusually direct: “It is not known if XANAX is safe and effective when used to treat anxiety disorder for longer than 4 months” and “not known if XANAX is safe and effective when used to treat panic disorder for longer than 10 weeks.” That doesn’t mean the drug stops working at exactly those time points, but it does mean no controlled study has proven it keeps working beyond them.
Some patients with panic disorder have taken Xanax for up to 8 months in open-label studies without losing its benefit. But open-label studies lack the rigor of placebo-controlled trials, so that evidence is weaker. The broader research on benzodiazepines as a class finds that while they’re effective for short-term anxiety management, they haven’t been shown to produce long-term improvement. Most clinical trials on anti-anxiety medications last four weeks or less, which leaves a real gap in what we know about sustained use.
When Dependence Develops
Xanax has a relatively short half-life of about 11 hours, which means it leaves your system faster than many other benzodiazepines. That’s partly why it’s effective for acute anxiety, but it’s also why your body can develop dependence quickly. Withdrawal symptoms are possible after just one month of daily use. By the eight-week mark, roughly 30% of patients experience some form of withdrawal when they stop.
In clinical terms, “long-term use” of benzodiazepines begins at two months of daily use at a therapeutic dose. That’s not an arbitrary cutoff. It reflects the point at which your brain has adapted enough to the drug that stopping abruptly becomes physically uncomfortable or even dangerous. The longer you take Xanax beyond that point, the harder it becomes to stop and the more structured the tapering process needs to be.
Cognitive Risks With Extended Use
The concern with long-term Xanax use goes beyond dependence. A 2017 meta-analysis found that prolonged benzodiazepine use impaired working memory, language processing, and processing speed. Executive functions like reasoning and planning were spared, but the other deficits were measurable and consistent across studies.
For older adults, the picture is more concerning. Multiple systematic reviews have linked benzodiazepine use to a higher risk of dementia and mild cognitive impairment. The risk correlates with three things: cumulative dose, how long you take the drug, and whether it’s a longer-acting formulation. Use extending beyond three years carried a notably higher dementia risk in one analysis of ten studies. People who took benzodiazepines at prescribed doses didn’t show significant differences from non-users on general cognitive screening tests, but those who exceeded recommended doses performed measurably worse.
Higher Doses Come With Extra Scrutiny
For panic disorder, Xanax is typically started at 0.5 mg three times daily, with increases no faster than 1 mg per day every three to four days. In clinical trials, the average daily dose for panic disorder landed around 5 to 6 mg, with some patients going as high as 10 mg. If you’re taking more than 4 mg per day, the FDA recommends periodic reassessment and consideration of a dose reduction. In a post-marketing study, patients on doses above 4 mg daily for three months were able to cut their dose in half without losing clinical benefit, which suggests many people end up on more than they need.
What Tapering Looks Like
Stopping Xanax is not something you do on your own, and it’s not something you do quickly. A typical taper lasts 8 to 12 weeks, though some people need longer. The initial dose reduction is usually between 5% and 25% of whatever you’re currently taking, followed by further reductions of 5% to 25% every one to four weeks depending on how you respond.
If you’re on a high dose, the first cut can be steeper, around 25% to 30%, before slowing to smaller 5% to 10% reductions. For people who’ve been on Xanax for a long time or at high doses, one strategy is to reduce by 50%, hold at that level for several months to let your body stabilize, and then resume tapering more gradually. The key principle is that the taper should be flexible. If withdrawal symptoms become unmanageable at any point, the pace slows down rather than pushing through.
Common withdrawal symptoms include rebound anxiety (often more intense than the original anxiety), insomnia, irritability, muscle tension, and in severe cases, seizures. The short half-life of Xanax makes its withdrawal profile sharper than longer-acting benzodiazepines, which is why some clinicians switch patients to a longer-acting drug before beginning the taper.
The Practical Takeaway
If you’ve been prescribed Xanax, the evidence supports using it for the shortest effective period, ideally weeks rather than months. The two- to four-week window recommended by the UK’s National Institute for Health and Clinical Excellence is a reasonable baseline for acute anxiety. For panic disorder, the data supports up to about 10 weeks of use, with some flexibility beyond that if the benefit clearly persists. Daily use beyond two months puts you in territory where dependence is likely and tapering becomes necessary rather than optional.
If you’re already past those time frames, that doesn’t mean you’ve done something wrong. It means any changes to your dose should be gradual, medically supervised, and paired with alternative approaches to managing your anxiety long-term.